Oxford University To Conclude Covid-19 Vaccine Trials By Nov-End, Mass Production In 2021

<strong>New Delhi: </strong>The Covid-19 vaccine being jointly manufactured by Oxford University and AstraZeneca is currently undergoing stage 3 clinical trials which will conclude by November end. <strong>ALSO READ | <span style="color: #ff0000;"><a style="color: #ff0000;" href="https://news.abplive.com/health/russian-vaccine-health-ministry-expert-recommends-its-coronavirus-vaccine-for-18-to-60-year-old-1311289">Russian Health Ministry Expert Recommends Its Covid-19 Vaccine For 18 To 60 Year Old For Now, Here's Why</a></span> </strong> An

source https://news.abplive.com/health/coronavirus-covid-19-vaccine-oxford-universitys-trials-to-conclude-by-nov-end-mass-production-in-2021-1311798